PROJECT SUMMARY
Youth involved in the legal system (YILS) have extremely high rates of substance and opioid use disorders
(SUD/OUD) and do not have access to the resources to prevent serious use sequelae. SUD prevention and
overdose prevention (harm reduction) interventions are critically important to delay escalation to synthetic
opioids and prevent fatalities and health/legal consequences. Washington State is facing an overdose crisis;
overdose deaths increased by 40% in a year, a steeper increase than any other state. Rural counties in this
state report overdose rates that are as high or higher than urban ones. Thus, rural YILS are particularly
vulnerable to overdose and lack adequate prevention services. Optimal SUD/OUD and overdose prevention
for rural YILS requires a multifaceted approach, which our experienced team is ideally poised to develop,
implement, and test. We have developed a successful hybrid remote-in person model in a previous grant
working with the state juvenile incarceration system that is ideally suited to serving rural county court-involved
YILS. We have strong support for this collaborative application from rural county court systems, who are
motivated to intervene with YILS earlier in the spectrum of legal system and substance use involvement.
Overall, the goal of the 2-year R61 phase will be to codesign a multilevel SUD/overdose strategy to prevent
escalation to OUD/overdose among YILS in rural county juvenile court systems, and the tools needed to
reliably implement this strategy. Specifically, we will collaboratively codesign components of a multilevel
SUD/overdose prevention strategy with a multisector group representing state and local governments,
service sector leaders, and consumer parents/YILS (R61 Aim 1). We will also codesign a reproducible
implementation plan for the multilevel intervention developed in Aim 1 that can be reliably implemented in
rural courts (R61 Aim 2). The overall goal of the 3-year R33 phase will be to test our codesigned strategy on
implementation and effectiveness outcomes. We will do this by conducting a hybrid type 2 stepped wedge
trial with 15 counties, surveying 470 youth (for an anticipated 360 complete cases) and tracking county
implementation metrics every three months to understand effects of multilevel intervention including
prevention education and harm reduction to reduce the harms attributable to active drug use. Outcomes will
include implementation (reach and adoption; R33 Aim 1) and effectiveness (overdose and naloxone
knowledge; frequency of use of overdose-associated and other substances; R33 Aim 2). This proposal is
innovative, high impact, and highly responsive to RFA-24-036. With our substance use prevention experience
and existing relationships with juvenile legal systems, we are uniquely positioned to be successful in
engaging diverse perspectives with rural legal systems to codesign and test a multilevel substance and
overdose prevention trial. The intervention and implementation processes we develop will be immediately
reproducible in other rural jurisdictions to address the needs of some of the highest risk youth in the country.
Public Health Relevance Statement
PROJECT NARRATIVE
Rural legally involved youth have high substance use rates yet cannot access needed prevention resources.
We will codesign a multilevel substance/overdose prevention intervention with diverse multisector partners
and input from a broad advisory board. We will use a stepped wedge hybrid 2 design to evaluate
implementation success/effectiveness in 15 rural county courts and 470 youth (360 complete cases).
No Sub Projects information available for 1R61DA061846-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R61DA061846-01
Patents
No Patents information available for 1R61DA061846-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R61DA061846-01
Clinical Studies
No Clinical Studies information available for 1R61DA061846-01
News and More
Related News Releases
No news release information available for 1R61DA061846-01
History
No Historical information available for 1R61DA061846-01
Similar Projects
No Similar Projects information available for 1R61DA061846-01